Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,009 across all filing types
Latest filing 2016-12-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
重大资产重组报告书(草案)及其摘要的修订说明公告
Regulatory Filings Classification · 95% confidence The document is titled as a "重大资产重组报告书(草案)及其摘要的修订说明公告" which translates to "Major Asset Restructuring Report (Draft) and its Summary Revision Announcement." It discusses revisions and supplementary disclosures to a previously announced major asset restructuring report, including updates on creditor consents, employee arrangements, performance commitments, risk disclosures, and corrections to the draft report. The document also mentions that the restructuring requires shareholder approval and regulatory review, indicating it is related to a significant corporate transaction. The document length is 1957 characters, which is relatively short and primarily serves as an announcement of revisions to the restructuring report rather than the full report itself. Therefore, it fits best under the category of a Regulatory Filing (RNS) as it is a regulatory announcement about the restructuring report revisions and related disclosures, not the full restructuring report or a merger filing itself.
2016-12-18 Chinese
北京市金杜律师事务所关于公司发行股份购买资产及重大资产出售暨关联交易之补充法律意见书(一)
Capital/Financing Update Classification · 95% confidence The document is a detailed legal opinion letter from a law firm (北京市金杜律师事务所) regarding a company's issuance of shares to purchase assets and a major asset sale, including related party transactions. It references specific Chinese securities laws and regulations, such as the "上市公司重大资产重组管理办法" (Measures for the Administration of Major Asset Restructuring of Listed Companies) and the Shenzhen Stock Exchange rules. The document discusses ownership structures, control relationships, voting rights, and compliance with regulatory requirements for a major asset restructuring transaction. It is a legal opinion supplement related to a significant corporate transaction involving issuance of shares and asset purchase, not a financial report or earnings release. It is not a simple announcement or a proxy statement but a detailed legal opinion on a major transaction. This fits best under the category of Capital/Financing Update (CAP), as it concerns issuance of shares for asset purchase and major asset sale, which are financing and capital structure related activities.
2016-12-18 Chinese
中信建投证券股份有限公司关于深圳证券交易所《关于对成都天兴仪表股份有限公司的重组问询函》相关问题之专项核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed response and independent financial advisor's verification related to a restructuring inquiry from the Shenzhen Stock Exchange concerning Chengdu Tianxing Instrument Co., Ltd. It discusses a major asset purchase and related performance commitments, shareholder agreements, control risks, and compliance with regulatory requirements. The content includes detailed financial and legal analysis, performance compensation agreements, and disclosures related to a significant corporate restructuring transaction. The document references a 'Restructuring Report' and includes independent financial advisor opinions verifying compliance and reasonableness of the transaction and related disclosures. This is characteristic of a detailed regulatory filing related to a major corporate restructuring and asset purchase transaction, including independent financial advisor reports and legal opinions. It is not a simple announcement, certification, or a brief summary but a comprehensive regulatory and advisory document related to a major transaction. Therefore, the most appropriate classification is 'Regulatory Filings' (RNS), as it is a regulatory response and verification document related to a restructuring inquiry and transaction, not the actual restructuring report itself or a proxy statement or merger filing.
2016-12-18 Chinese
关于重大资产重组媒体说明会召开情况的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a major asset restructuring involving Chengdu Tianxing Instrument Co., Ltd. It includes extensive information about the transaction structure, valuation, legal and financial advisor opinions, industry background, and operational details of the target company. The content focuses on a significant asset purchase and sale, with detailed explanations from financial advisors, auditors, legal counsel, and company executives. The document is lengthy (15,000 characters) and contains substantive financial and operational data related to the restructuring. It is not a brief announcement or a simple notification but a comprehensive disclosure about a major asset restructuring event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset restructurings.
2016-12-14 Chinese
关于召开媒体说明会的提示性公告
Regulatory Filings Classification · 95% confidence The document is a notice about a media briefing related to a major asset restructuring before the company's stock resumption. It announces the time, place, participants, and agenda of the media explanation meeting. It does not contain financial statements, detailed financial data, or the actual asset restructuring report. It is an announcement about an event (media briefing) rather than the event's content or a formal report. The document length is short (1675 characters), and it primarily serves as a notification to the public and investors about the upcoming media meeting. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2016-12-12 Chinese
重大资产重组进展公告
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产重组进展公告" which translates to "Major Asset Restructuring Progress Announcement." It details a series of announcements and updates regarding a significant asset restructuring event, including stock suspension dates, board meetings, and regulatory review status. The document is relatively short (1387 characters) and primarily provides progress updates and notices about the ongoing restructuring process rather than the full details of the restructuring itself. It does not contain comprehensive financial statements or detailed financial analysis. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset restructurings. Therefore, the appropriate classification is CAP with high confidence.
2016-12-11 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.